Tenax Therapeutics Inc (TENX) — Cash Flow-to-Debt Ratio
Tenax Therapeutics Inc (TENX) has a Cash Flow-to-Debt Ratio of -1.87x as of December 2025, meaning its operating cash flow of $-13.41 Million could theoretically repay -2% of its total liabilities ($7.16 Million) in one year. See TENX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Tenax Therapeutics Inc Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Tenax Therapeutics Inc across 31 annual periods. Also explore Tenax Therapeutics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Tenax Therapeutics Inc (1995–2025)
Year-by-year debt coverage analysis for Tenax Therapeutics Inc. For market capitalisation and broader financial context, see market value of Tenax Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.00x | $-35.80 Million | $7.16 Million | ▼ -58.5% |
| 2024 | -3.16x | $-14.81 Million | $4.69 Million | ▼ -91.7% |
| 2023 | -1.65x | $-5.90 Million | $3.59 Million | ▲ +73.8% |
| 2022 | -6.28x | $-12.01 Million | $1.91 Million | ▼ -1.1% |
| 2021 | -6.21x | $-10.86 Million | $1.75 Million | ▼ -50.3% |
| 2020 | -4.13x | $-9.27 Million | $2.24 Million | ▼ -41.8% |
| 2019 | -2.91x | $-7.56 Million | $2.59 Million | ▲ +17.0% |
| 2018 | -3.51x | $-5.50 Million | $1.57 Million | ▲ +70.8% |
| 2017 | -12.03x | $-12.14 Million | $1.01 Million | ▼ -370.0% |
| 2016 | -2.56x | $-15.87 Million | $6.20 Million | ▼ -229.9% |
| 2015 | -0.78x | $-9.75 Million | $12.56 Million | ▲ +11.7% |
| 2014 | -0.88x | $-9.26 Million | $10.54 Million | ▲ +0.0% |
| 2013 | -0.88x | $-9.26 Million | $10.54 Million | ▲ +35.1% |
| 2012 | -1.35x | $-4.92 Million | $3.64 Million | ▼ -8.9% |
| 2011 | -1.24x | $-8.40 Million | $6.76 Million | ▲ +79.7% |
| 2010 | -6.12x | $-8.59 Million | $1.40 Million | ▼ -81.0% |
| 2009 | -3.38x | $-4.06 Million | $1.20 Million | ▼ -166.5% |
| 2008 | -1.27x | $-2.28 Million | $1.79 Million | ▼ -174.6% |
| 2007 | -0.46x | $-1.14 Million | $2.46 Million | ▲ +90.9% |
| 2006 | -5.06x | $-2.15 Million | $424.57K | ▲ +20.3% |
| 2005 | -6.34x | $-1.99 Million | $313.94K | ▼ -29.3% |
| 2004 | -4.91x | $-1.77 Million | $361.51K | ▲ +21.8% |
| 2003 | -6.27x | $-2.09 Million | $333.75K | ▲ +73.0% |
| 2002 | -23.27x | $-1.90 Million | $81.55K | ▼ -502.6% |
| 2001 | -3.86x | $-1.54 Million | $398.09K | ▼ -46.1% |
| 2000 | -2.64x | $-913.30K | $345.44K | ▼ -98.3% |
| 1999 | -1.33x | $-800.00K | $600.00K | ▼ -46.9% |
| 1998 | -0.91x | $-575.69K | $634.36K | ▲ +37.5% |
| 1997 | -1.45x | $-872.15K | $600.67K | ▲ +5.9% |
| 1996 | -1.54x | $-1.53 Million | $991.54K | ▲ +0.0% |
| 1995 | -1.54x | $-1.53 Million | $991.54K | — |